Efficacy and Safety of Tofacitinib in Patients with Polymyalgia Rheumatica (EAST PMR): An open-label randomized controlled trial

Xinlei Ma and co-workers investigate tofacitinib as a possible treatment for patients with polymyalgia rheumatica.

Related Keywords

China ,Zhejiang ,Helsinki ,Eteläuomen Läi ,Finland ,Kyoto ,Japan ,Chinese , ,China National Center ,National Key Research ,Zhejiang University School Of Medicine ,National Genomics Data Center Nucleic Acids Res ,Chinese Academy Of Sciences ,Bioinformation Beijing Institute Of Genomics ,Development Program Of China ,Library Prep Kit For Illumina ,Ethical Committee Of The First Affiliated Hospital ,Natural Science Foundation Of China ,First Affiliated Hospital ,Zhejiang University School ,Polymyalgia Rheumatica ,Creative Commons Attribution License ,Genome Sequence Archive ,National Genomics Data Center ,Nucleic Acids Res ,Beijing Institute ,Chinese Academy ,Natural Science Foundation ,Development Program ,Gene Ontology ,Kyoto Encyclopedia ,Medical Ethical Committee ,Consolidated Standards ,Reporting Trials ,Prep Kit ,Illumina Novaseq ,Oral Prednisone ,Glucocorticoid Therapy ,Gene Expression ,Inflammation ,C Reactive Proteins ,Pathogenesis ,Immune Receptor Signaling ,Inflammatory Diseases ,